where to inject semaglutide in arm How Semaglutide: A Step-by-Step Guide How to Inject Your Semaglutide/Tirzepatide

Terui K, Komatsu K, Shinozuka S, et al

Epub 2020 Jul 31

Is transient and dose-dependent, peaking 12 hours post-injection and resolving within 46 hours

Rare Emerging Adverse Cutaneous Reactions Dermal Hypersensitivity The most reported cutaneous adverse drug reaction (ADR) occurring during GLP-1 RAs treatment is dermal hypersensitivity (DHS)

Originally derived from a protein in the stomach, it has shown benefits in tissue repair, joint healing, and gastrointestinal recovery

Together these findings demonstrate a role for ACSL1 in the incorporation of ESA and other fatty acids into DAGs/TAGs, which could suggest a role for lipid droplets in ESA-induced ferroptosis